We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens Renews Contract with Premier Purchasing Partners

By LabMedica International staff writers
Posted on 06 Apr 2010
Siemens Healthcare Diagnostics (Deerfield, IL, USA) announced a new three-year contract with Premier Purchasing Partners, L.P. More...
(San Diego, CA, USA), the group-purchasing unit of Premier Inc. The new contract, which became effective April 1, 2010, continues Siemens' long-standing relationship with Premier, providing members with ongoing access to Siemens' comprehensive portfolio of diagnostic systems, tests, and automation solutions.

Siemens provides Premier members with a complete line of products: chemistry, immunoassay, automation, coagulation, microbiology, cardiac, drug testing, molecular, blood gas, and urinalysis solutions. These include Dimension and Dimension Vista integrated chemistry systems, Advia immunoassay and clinical chemistry systems, Stratus CS Acute Cardiac Care System and Syva reagents, as well as the Siemens family of plasma protein analyzers, and Viva drug testing systems. Premier members are offered a menu of Siemens' diagnostic tests to help detect and monitor a variety of health conditions, ranging from heart disease to diabetes and cancer.

A sole-source agreement was also awarded to Siemens covering all of the same products for members participating in Premier's Accelerated Supply Chain Endeavor (ASCEND) program.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry particularly in laboratory diagnostics, medical imaging, medical information technology, and hearing aids. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective.

The Premier healthcare alliance is comprised of more than 2,300 U.S. hospitals and 64,000-plus other healthcare sites. The alliance operates a leading healthcare purchasing network and maintains a comprehensive repository of clinical, financial, and outcomes information.

Related Links:
Siemens Healthcare Diagnostics
Premier Purchasing Partners, L.P.


New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Hematology Consumables
Bioblood Devices
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.